N
Natasha K. Martin
Researcher at University of California, San Diego
Publications - 178
Citations - 8828
Natasha K. Martin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Population & Hepatitis C. The author has an hindex of 41, co-authored 158 publications receiving 7214 citations. Previous affiliations of Natasha K. Martin include University of Oxford & University of London.
Papers
More filters
Journal ArticleDOI
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway,Abraham D. Flaxman,Mohsen Naghavi,Christina Fitzmaurice,Christina Fitzmaurice,Theo Vos,Ibrahim Abubakar,Laith J. Abu-Raddad,Reza Assadi,Neeraj Bhala,Neeraj Bhala,Benjamin C Cowie,Mohammad H. Forouzanfour,Justina Groeger,Khayriyyah Mohd Hanafiah,Khayriyyah Mohd Hanafiah,Kathryn H. Jacobsen,Spencer L. James,Jennifer H MacLachlan,Reza Malekzadeh,Natasha K. Martin,Natasha K. Martin,Ali A. Mokdad,Ali H. Mokdad,Christopher J L Murray,Dietrich Plass,Saleem M Rana,David B. Rein,Jan Hendrik Richardus,Juan Sanabria,Juan Sanabria,Mete Saylan,Saeid Shahraz,Samuel So,Vasiliy Victorovich Vlassov,Elisabete Weiderpass,Steven T. Wiersma,Mustafa Z. Younis,Chuanhua Yu,Maysaa El Sayed Zaki,Graham S Cooke +40 more
TL;DR: The enormous health loss attributable to viral hepatitis, and the availability of effective vaccines and treatments, suggests an important opportunity to improve public health.
Journal ArticleDOI
Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
Roger Williams,Richard Aspinall,Mark A Bellis,Ginette Camps-Walsh,Matthew E. Cramp,Anil Dhawan,James Ferguson,Daniel M. Forton,Graham R. Foster,Sir Ian Gilmore,Matthew Hickman,Mark Hudson,Deirdre Kelly,Andrew Langford,Martin Lombard,Louise Longworth,Natasha K. Martin,Kieran Moriarty,Philip N. Newsome,John O'Grady,Rachel Pryke,Harry Rutter,Stephen D. Ryder,Nick Sheron,Thomas J. Smith +24 more
TL;DR: The aim of this Commission is to provide the strongest evidence base through involvement of experts from a wide cross-section of disciplines, making firm recommendations to reduce the unacceptable premature mortality and disease burden from avoidable causes and to improve the standard of care for patients with liver disease in hospital.
Journal ArticleDOI
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin,Peter Vickerman,Jason Grebely,Margaret Hellard,Sharon J. Hutchinson,Viviane D. Lima,Graham R. Foster,John F. Dillon,David J. Goldberg,Gregory J. Dore,Matthew Hickman +10 more
TL;DR: In this article, the authors projected the potential impact of interferon-free direct-acting antiviral (DAA) treatments on hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) in three settings.
Journal ArticleDOI
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
Julian P T Higgins,Karla Soares-Weiser,José A López-López,Artemisia Kakourou,Katherine Chaplin,Hannah Christensen,Natasha K. Martin,Natasha K. Martin,Jonathan A C Sterne,Arthur Reingold +9 more
TL;DR: Evidence suggests that receipt of BCG and MCV reduce overall mortality by more than would be expected through their effects on the diseases they prevent, and receipt of DTP may be associated with an increase in all cause mortality.
Journal ArticleDOI
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.
Georgina J MacArthur,Silvia Minozzi,Natasha K. Martin,Natasha K. Martin,Peter Vickerman,Peter Vickerman,Sherry Deren,Julie Bruneau,Louisa Degenhardt,Louisa Degenhardt,Matthew Hickman +10 more
TL;DR: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs, which could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour.